NatCure Sciences, Inc.
NatCure, a private start-up company, seeks funding for drug development of a plant-derived compound for autoimmune disease treatment
- Stage Product In Development
- Industry Biotechnology
- Location Boston, MA, USA
- Currency USD
- Founded March 2010
- Employees 4
- Website natcure.com
Company Summary
NatCure Sciences is a biopharmaceutical discovery company developing drug products isolated from plant extracts with history in traditional medicine from Africa and China. The lead product NAT-100 is being developed to treat Inflammatory Bowel Disease (IBD) and Multiple Sclerosis (MS). The active NAT-100 compound is water soluble with anti-inflammatory and immunosuppressive activity with little or no known-toxicity in man.
Team
-
Harout DerSimonian, PhDFounder and CEO/CSO
Former assistant professor at Harvard Medical School and assistant immunologist at Massachusetts General Hospital. 20+ years of research and development experience in biotechnology with expertise in autoimmunity and transplantationdevelopment experience in biotechnology with expertise in autoimmunity and transplantation
-
Abdellah Sentissi, PhDVP, Drug Development and Quality Management
Chemist, Pharmacist, and Biologist with 20+ years experience in creating and managing quality control laboratories and developing and implementing quality systems for biotechnology companies. Extensive experience in pharmaceutical Sciences with expertise in Quality Assurance and Drug Development
-
Christopher Braudis Jr, MSc, RQAP-GLPDirector of Operations
Experienced professional in GxP regulations, Quality Assurance, Regulatory Affairs, Auditing, Computer System Validation, Bioanalytical Method Validation, and Bioanalytical Sample Analysis
Advisors
-
Jeffrey L. Quillen, Foley Hoag LLPLawyerUnconfirmedRobert Baker, Baker O'Connor & CoAccountantUnconfirmed
Previous Investors
-
Harout DerSimonian - founderUnconfirmedAmerican Chemical Society - ACS Entrepreneurial InitiativeUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.